Titelia

Fund shareholders of Takeda Pharmaceutical Co Ltd

ISIN JP3463000004 · Japan · LEI 549300ZLMVP4X0OGR454

Fund shareholders
414
Of which ETFs
102 312 other funds
Value held
8B $ 1.9B SEK · 8.3M €

This issuer has other securities : Takeda Pharmaceutical Co Ltd (US8740602052)

414 funds hold this company. This table lists the 408 that declare it in a regulatory filing. The other 6 publish their holdings in their own reports. They are not in the table.

FundSharesValueWeight in fund
KUTXABANK BOLSA JAPON, FI KUTXABANK GESTION, SGIIC, S.A. 1.3M €0.32 %as of Dec 31, 2025 ↗
BBVA BOLSA INDICE JAPON (CUBIERTO), FI BBVA ASSET MANAGEMENT, S.A., SGIIC 604K €1.04 %as of Dec 31, 2025 ↗
SIGMA INVESTMENT HOUSE HEALTHCARE, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. 268.6K €0.69 %as of Dec 31, 2025 ↗
BBVA MEGATENDENCIA DEMOGRAFIA, FI BBVA ASSET MANAGEMENT, S.A., SGIIC 197K €1.30 %as of Dec 31, 2025 ↗
INVERSABADELL 25, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. 134.1K €0.02 %as of Dec 31, 2025 ↗
INVERSABADELL 50, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. 99.9K €0.04 %as of Dec 31, 2025 ↗
INVERSABADELL 70, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. 39.4K €0.06 %as of Dec 31, 2025 ↗
SABADELL PLANIFICACION, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. 36.8K €0.02 %as of Dec 31, 2025 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
iShares Genomics Immunology and Healthcare ETF iShares Trust 4.22 %as of Apr 30, 2026 ↗
Federated Hermes International Strategic Value Dividend Fund Federated Hermes Equity Funds 2.65 %as of Feb 28, 2026 ↗
Lazard Japanese Equity ETF Lazard Active ETF Trust 2.60 %as of Mar 31, 2026 ↗
Brandes International Equity Fund Datum One Series Trust 2.60 %as of Mar 31, 2026 ↗
Brandes International ETF 2023 ETF Series Trust 2.57 %as of Mar 31, 2026 ↗
Pictet - Japanese Equity Selection Pictet Asset Management (Europe) S.A. 2.54 %as of Sep 30, 2025 ↗
ALPS International Sector Dividend Dogs ETF ALPS ETF TRUST 2.33 %as of Feb 28, 2026 ↗
iShares MSCI Japan Value ETF iShares Trust 2.14 %as of Feb 28, 2026 ↗
WisdomTree Japan Hedged Equity Fund WisdomTree Trust 2.05 %as of Mar 31, 2026 ↗
Pacer Developed Markets International Cash Cows 100 ETF Pacer Funds Trust 2.04 %as of Apr 30, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterShareholdersChangeSharesChange
2026Q2348+40228,766,378+13.8 %
2026Q1308-33201,018,403-1.7 %
2025Q4341+13204,505,920+6.6 %
2025Q3328+14191,884,310+2.9 %
2025Q2314+10186,411,606+4.2 %
2025Q1304-16178,842,114-3.8 %
2024Q4320-6185,864,047-3.3 %
2024Q3326-6192,296,551-0.6 %
2024Q2332+6193,554,394+9.5 %
2024Q1326-5176,697,457-19.8 %
2023Q4331220,348,589

Funds holding the debt of Takeda Pharmaceutical Co Ltd

197 funds declare 466 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.

FundBond linesValue
VANGUARD TOTAL BOND MARKET II INDEX FUND8143.1M $as of Mar 31, 2026
VANGUARD TOTAL BOND MARKET INDEX FUND7127.1M $as of Mar 31, 2026
VANGUARD SHORT-TERM CORPORATE BOND INDEX FUND273.6M $as of Feb 28, 2026
iShares iBoxx $ Investment Grade Corporate Bond ETF656M $as of Feb 28, 2026
VANGUARD WELLINGTON FUND350.6M $as of Feb 28, 2026
iShares Core U.S. Aggregate Bond ETF946.4M $as of Feb 28, 2026
VANGUARD TOTAL INTERNATIONAL BOND II INDEX FUND534.8M $as of Apr 30, 2026
VANGUARD SHORT-TERM INVESTMENT-GRADE FUND233.1M $as of Apr 30, 2026
VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND131.2M $as of Feb 28, 2026
JPMorgan Core Bond Fund430.3M $as of Feb 28, 2026
VANGUARD TOTAL INTERNATIONAL BOND INDEX FUND427.1M $as of Apr 30, 2026
iShares 1-5 Year Investment Grade Corporate Bond ETF224.2M $as of Feb 28, 2026
VANGUARD SHORT-TERM BOND INDEX FUND223M $as of Mar 31, 2026
VANGUARD LONG-TERM CORPORATE BOND INDEX FUND422.6M $as of Feb 28, 2026
iShares Broad USD Investment Grade Corporate Bond ETF919.6M $as of Feb 28, 2026
VANGUARD INTERMEDIATE-TERM INVESTMENT-GRADE FUND118.8M $as of Apr 30, 2026
Fidelity Series Bond Index Fund615.7M $as of Feb 28, 2026
Invesco BulletShares 2030 Corporate Bond ETF114.8M $as of Feb 28, 2026
Invesco BulletShares 2028 Corporate Bond ETF114.4M $as of Feb 28, 2026
iShares iBonds Dec 2028 Term Corporate ETF112.2M $as of Apr 30, 2026
iShares iBonds Dec 2030 Term Corporate ETF111.5M $as of Apr 30, 2026
Fidelity U.S. Bond Index Fund111.1M $as of Feb 28, 2026
Baird Core Plus Bond Fund110.7M $as of Mar 31, 2026
VANGUARD INSTITUTIONAL SHORT-TERM BOND FUND110.1M $as of Mar 31, 2026
VANGUARD ULTRA-SHORT-TERM BOND FUND110.1M $as of Apr 30, 2026
Cite this page

Titelia. "Fund shareholders of Takeda Pharmaceutical Co Ltd". https://titelia.com/en/stocks/takeda-pharmaceutical-co-ltd-JP3463000004